CHEMOTHERAPY
Online ISSN : 1884-5894
Print ISSN : 0009-3165
ISSN-L : 0009-3165
Ticarcillinの基礎的・臨床的研究
慢性呼吸器感染症を中心に
松本 慶蔵宇塚 良夫野口 行雄渡辺 貴和雄鈴木 寛永武 毅玉置 公俊羅 士易井手 政利
著者情報
ジャーナル フリー

1977 年 25 巻 9 号 p. 2641-2649

詳細
抄録

Laboratory and clinical studies on ticarcillin were performed with following results.
1. Antibacterial activity of ticarcillin against respiratory pathogenic bacteria isolated from sputum was measured.
1) MIC values against 80 strains of Haemophilus influenzae ranged from 0.1 to 0.78 μg/ml. Ticarcillin was active as much as ampicillin, and slightly superior to amoxycillin, carbenicillin and sulbenicillin. There was no resistant strain against ticarcillin.
2) Against sensitive group of 34 strains of Pseudomonas aeruginosa, the activity of ticarcillin was 2 times superior to sulbenicillin and 4 times superior to carbenicillin. But against resistant strains, MICs of ticarcillin were same as those of sulbenicillin and carbenicillin.
2. After intramuscular administration of ticarcillin 100 mg/kg in rats, the concentrations of organs reached peak levels at 15 minutes and they were the following order of kidney, liver, serum and lung. Two to 4 hours later, ticarcillin was not detectable in all organs.
3. Nine patients with chronic respiratory tract infections were administered ticarcillin by intravenous drip infusion, and the concentrations in serum, saliva, sputum and intrabronchial secretions were measured. Serum levels of ticarcillin showed dose response according to administration dose volume and instillation time. The half life in serum was between 40 to 60 minutes. Probenecid prolonged the half-life of ticarcillin in all 4patients, and elevated the sputum level, too.
4. Ten patients with chronic respiratory infections (chronic bronchitis; 3, bronchiectasis; 3, chronic bronchiolitis; 4) were treated with intravenous drip infusion of ticarcillin 3 to 20 g a day for 5 to 14 days. Treatment succeeded in all of 8 patients infected with Haemophilus influenzae, and in one of 5 patients infected with Pseudomonas aeruginosa. Effects of ticarcillin for bacterial respiratory infections depended on transported concentration into infected bronchus and susceptibility of causative agents to ticarcillin.
5. There was no adverse reaction.

著者関連情報
© 社団法人日本化学療法学会
前の記事 次の記事
feedback
Top